Report Detail

Other Impact of COVID-19 Outbreak on Artificial Cardiopulmonary Machine, Global Market Research Report 2020

  • RnM3973871
  • |
  • 22 May, 2020
  • |
  • Global
  • |
  • 99 Pages
  • |
  • QYResearch
  • |
  • Other

1 Artificial Cardiopulmonary Machine Market Overview

  • 1.1 Product Overview and Scope of Artificial Cardiopulmonary Machine
  • 1.2 Covid-19 Impact on Artificial Cardiopulmonary Machine Segment by Type
    • 1.2.1 Global Artificial Cardiopulmonary Machine Production Growth Rate Comparison by Type 2020 VS 2026
    • 1.2.2 Single Roller Pump HLM
    • 1.2.3 Double Roller Pump HLM
  • 1.3 Covid-19 Impact on Artificial Cardiopulmonary Machine Segment by Application
    • 1.3.1 Artificial Cardiopulmonary Machine Consumption Comparison by Application: 2020 VS 2026
    • 1.3.2 Cardiac Surgery
    • 1.3.3 Lung Transplant Operation
    • 1.3.4 Acute Respiratory Failure Treatment
    • 1.3.5 Others
  • 1.4 Covid-19 Impact on Global Artificial Cardiopulmonary Machine Market by Region
    • 1.4.1 Global Artificial Cardiopulmonary Machine Market Size Estimates and Forecasts by Region: 2020 VS 2026
    • 1.4.2 North America Estimates and Forecasts (2015-2026)
    • 1.4.3 Europe Estimates and Forecasts (2015-2026)
    • 1.4.4 China Estimates and Forecasts (2015-2026)
    • 1.4.5 Japan Estimates and Forecasts (2015-2026)
  • 1.5 Covid-19 Impact on Global Artificial Cardiopulmonary Machine Growth Prospects
    • 1.5.1 Global Artificial Cardiopulmonary Machine Revenue Estimates and Forecasts (2015-2026)
    • 1.5.2 Global Artificial Cardiopulmonary Machine Production Capacity Estimates and Forecasts (2015-2026)
    • 1.5.3 Global Artificial Cardiopulmonary Machine Production Estimates and Forecasts (2015-2026)
  • 1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 The Covid-19 Impact on Artificial Cardiopulmonary Machine Industry
  • 1.8 COVID-19 Impact: Artificial Cardiopulmonary Machine Market Trends

2 Covid-19 Impact on Market Competition by Manufacturers

  • 2.1 Global Artificial Cardiopulmonary Machine Production Capacity Market Share by Manufacturers (2015-2020)
  • 2.2 Global Artificial Cardiopulmonary Machine Revenue Share by Manufacturers (2015-2020)
  • 2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Artificial Cardiopulmonary Machine Average Price by Manufacturers (2015-2020)
  • 2.5 Manufacturers Artificial Cardiopulmonary Machine Production Sites, Area Served, Product Types
  • 2.6 Artificial Cardiopulmonary Machine Market Competitive Situation and Trends
    • 2.6.1 Artificial Cardiopulmonary Machine Market Concentration Rate
    • 2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Covid-19 Impact on Production and Capacity by Region

  • 3.1 Global Production Capacity of Artificial Cardiopulmonary Machine Market Share by Regions (2015-2020)
  • 3.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Regions (2015-2020)
  • 3.3 Global Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.4 North America Artificial Cardiopulmonary Machine Production
    • 3.4.1 North America Artificial Cardiopulmonary Machine Production Growth Rate (2015-2020)
    • 3.4.2 North America Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.5 Europe Artificial Cardiopulmonary Machine Production
    • 3.5.1 Europe Artificial Cardiopulmonary Machine Production Growth Rate (2015-2020)
    • 3.5.2 Europe Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.6 China Artificial Cardiopulmonary Machine Production
    • 3.6.1 China Artificial Cardiopulmonary Machine Production Growth Rate (2015-2020)
    • 3.6.2 China Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.7 Japan Artificial Cardiopulmonary Machine Production
    • 3.7.1 Japan Artificial Cardiopulmonary Machine Production Growth Rate (2015-2020)
    • 3.7.2 Japan Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Covid-19 Impact on Global Artificial Cardiopulmonary Machine Consumption by Regions

  • 4.1 Global Artificial Cardiopulmonary Machine Consumption by Regions
    • 4.1.1 Global Artificial Cardiopulmonary Machine Consumption by Region
    • 4.1.2 Global Artificial Cardiopulmonary Machine Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Artificial Cardiopulmonary Machine Consumption by Countries
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Artificial Cardiopulmonary Machine Consumption by Countries
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Artificial Cardiopulmonary Machine Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Artificial Cardiopulmonary Machine Consumption by Countries
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Covid-19 Impact on Artificial Cardiopulmonary Machine Production, Revenue, Price Trend by Type

  • 5.1 Global Artificial Cardiopulmonary Machine Production Market Share by Type (2015-2020)
  • 5.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2015-2020)
  • 5.3 Global Artificial Cardiopulmonary Machine Price by Type (2015-2020)
  • 5.4 Global Artificial Cardiopulmonary Machine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Covid-19 Impact on Global Artificial Cardiopulmonary Machine Market Analysis by Application

  • 6.1 Global Artificial Cardiopulmonary Machine Consumption Market Share by Application (2015-2020)
  • 6.2 Global Artificial Cardiopulmonary Machine Consumption Growth Rate by Application (2015-2020)

7 Covid-19 Impact on Company Profiles and Key Figures in Artificial Cardiopulmonary Machine Business

  • 7.1 LivaNova (Sorin)
    • 7.1.1 LivaNova (Sorin) Artificial Cardiopulmonary Machine Production Sites and Area Served
    • 7.1.2 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Introduction, Application and Specification
    • 7.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.1.4 LivaNova (Sorin) Main Business and Markets Served
  • 7.2 Getinge (Maquet)
    • 7.2.1 Getinge (Maquet) Artificial Cardiopulmonary Machine Production Sites and Area Served
    • 7.2.2 Getinge (Maquet) Artificial Cardiopulmonary Machine Product Introduction, Application and Specification
    • 7.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.2.4 Getinge (Maquet) Main Business and Markets Served
  • 7.3 Medtronic
    • 7.3.1 Medtronic Artificial Cardiopulmonary Machine Production Sites and Area Served
    • 7.3.2 Medtronic Artificial Cardiopulmonary Machine Product Introduction, Application and Specification
    • 7.3.3 Medtronic Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.3.4 Medtronic Main Business and Markets Served
  • 7.4 Terumo CV Group
    • 7.4.1 Terumo CV Group Artificial Cardiopulmonary Machine Production Sites and Area Served
    • 7.4.2 Terumo CV Group Artificial Cardiopulmonary Machine Product Introduction, Application and Specification
    • 7.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.4.4 Terumo CV Group Main Business and Markets Served
  • 7.5 Braile Biomedica
    • 7.5.1 Braile Biomedica Artificial Cardiopulmonary Machine Production Sites and Area Served
    • 7.5.2 Braile Biomedica Artificial Cardiopulmonary Machine Product Introduction, Application and Specification
    • 7.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.5.4 Braile Biomedica Main Business and Markets Served
  • 7.6 Tianjin Medical
    • 7.6.1 Tianjin Medical Artificial Cardiopulmonary Machine Production Sites and Area Served
    • 7.6.2 Tianjin Medical Artificial Cardiopulmonary Machine Product Introduction, Application and Specification
    • 7.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.6.4 Tianjin Medical Main Business and Markets Served

8 Artificial Cardiopulmonary Machine Manufacturing Cost Analysis

  • 8.1 Artificial Cardiopulmonary Machine Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
  • 8.4 Artificial Cardiopulmonary Machine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Artificial Cardiopulmonary Machine Distributors List
  • 9.3 Artificial Cardiopulmonary Machine Customers

10 Market Dynamics

  • 10.1 Market Trends
  • 10.2 Opportunities and Drivers
  • 10.3 Challenges
  • 10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Artificial Cardiopulmonary Machine (2021-2026)
  • 11.2 Global Forecasted Revenue of Artificial Cardiopulmonary Machine (2021-2026)
  • 11.3 Global Forecasted Price of Artificial Cardiopulmonary Machine (2021-2026)
  • 11.4 Global Artificial Cardiopulmonary Machine Production Forecast by Regions (2021-2026)
    • 11.4.1 North America Artificial Cardiopulmonary Machine Production, Revenue Forecast (2021-2026)
    • 11.4.2 Europe Artificial Cardiopulmonary Machine Production, Revenue Forecast (2021-2026)
    • 11.4.3 China Artificial Cardiopulmonary Machine Production, Revenue Forecast (2021-2026)
    • 11.4.4 Japan Artificial Cardiopulmonary Machine Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted and Consumption Demand Analysis of Artificial Cardiopulmonary Machine
  • 12.2 North America Forecasted Consumption of Artificial Cardiopulmonary Machine by Country
  • 12.3 Europe Market Forecasted Consumption of Artificial Cardiopulmonary Machine by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Artificial Cardiopulmonary Machine by Regions
  • 12.5 Latin America Forecasted Consumption of Artificial Cardiopulmonary Machine

13 Forecast by Type and by Application (2021-2026)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
    • 13.1.1 Global Forecasted Production of Artificial Cardiopulmonary Machine by Type (2021-2026)
    • 13.1.2 Global Forecasted Revenue of Artificial Cardiopulmonary Machine by Type (2021-2026)
    • 13.1.2 Global Forecasted Price of Artificial Cardiopulmonary Machine by Type (2021-2026)
  • 13.2 Global Forecasted Consumption of Artificial Cardiopulmonary Machine by Application (2021-2026)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Artificial Cardiopulmonary Machine market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the Artificial Cardiopulmonary Machine industry.

    Segment by Type
    Single Roller Pump HLM
    Double Roller Pump HLM

    Segment by Application
    Cardiac Surgery
    Lung Transplant Operation
    Acute Respiratory Failure Treatment
    Others

    Global Artificial Cardiopulmonary Machine Market: Regional Analysis
    The report offers in-depth assessment of the growth and other aspects of the Artificial Cardiopulmonary Machine market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
    The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

    Global Artificial Cardiopulmonary Machine Market: Competitive Landscape
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
    The major players in the market include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical, etc.


    Summary:
    Get latest Market Research Reports on Artificial Cardiopulmonary Machine. Industry analysis & Market Report on Artificial Cardiopulmonary Machine is a syndicated market report, published as Impact of COVID-19 Outbreak on Artificial Cardiopulmonary Machine, Global Market Research Report 2020. It is complete Research Study and Industry Analysis of Artificial Cardiopulmonary Machine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,361.74
    3,542.61
    4,723.49
    2,638.90
    3,958.36
    5,277.81
    312,443.10
    468,664.65
    624,886.20
    219,619.03
    329,428.55
    439,238.06
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report